KCM Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$603K Sell
9,602
-676
-7% -$54.1K 0.02% 245
2025
Q4
$980K Buy
10,278
+76
+0.7% +$7.45K 0.03% 218
2025
Q3
$996K Buy
10,202
+272
+3% +$28.2K 0.03% 213
2025
Q2
$1.07M Buy
9,930
+876
+10% +$88.6K 0.04% 209
2025
Q1
$913K Sell
9,054
-4
-0% -$403 0.03% 214
2024
Q4
$809K Sell
9,058
-68
-0.7% -$5.99K 0.03% 219
2024
Q3
$765K Sell
9,126
-99
-1% -$7.8K 0.03% 229
2024
Q2
$710K Hold
9,225
0.03% 234
2024
Q1
$632K Buy
9,225
+150
+2% +$9.64K 0.02% 246
2023
Q4
$525K Sell
9,075
-1,146
-11% -$61.2K 0.02% 247
2023
Q3
$540K Sell
10,221
-200
-2% -$10.5K 0.02% 242
2023
Q2
$564K Hold
10,421
0.02% 249
2023
Q1
$521K Buy
10,421
+45
+0.4% +$2.12K 0.02% 265
2022
Q4
$480K Buy
10,376
+578
+6% +$25K 0.02% 269
2022
Q3
$379K Hold
9,798
0.02% 275
2022
Q2
$365K Hold
9,798
0.02% 299
2022
Q1
$434K Buy
9,798
+1,163
+13% +$50.4K 0.02% 307
2021
Q4
$367K Hold
8,635
0.01% 321
2021
Q3
$375K Sell
8,635
-45
-0.5% -$1.99K 0.01% 302
2021
Q2
$371K Hold
8,680
0.02% 304
2021
Q1
$335K Buy
8,680
+1,076
+14% +$40.7K 0.01% 299
2020
Q4
$273K Buy
+7,604
New +$274K 0.01% 300

Other funds holding BSX

KCM Investment Advisors's BSX Position: Q1 2026 in Review

KCM Investment Advisors reduced its Boston Scientific (BSX) stake by 6.6% in Q1 2026, selling an estimated $54.1K and leaving 9,602 shares worth $603K. The position accounts for 0.02% of the portfolio, ranked #245.

KCM Investment Advisors first reported a position in BSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.07M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • KCM Investment Advisors held 9,602 shares of Boston Scientific worth $603K as of Q1 2026.
  • KCM Investment Advisors sold 676 Boston Scientific shares in Q1 2026, an estimated $54.1K.
  • Boston Scientific made up 0.02% of KCM Investment Advisors's portfolio in Q1 2026, its #245 holding.
  • KCM Investment Advisors first reported a position in Boston Scientific in Q4 2020 and has held it in 22 quarters since.
  • KCM Investment Advisors's Boston Scientific position peaked at $1.07M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on KCM Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.